NCT04241419

Brief Summary

The purpose of this pilot study is to evaluate a high intensity walking intervention in older surgical candidates with kidney or thoracic disease and pre-frailty or frailty.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 22, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2023

Completed
Last Updated

October 23, 2024

Status Verified

October 1, 2024

Enrollment Period

4.3 years

First QC Date

January 22, 2020

Last Update Submit

October 21, 2024

Conditions

Keywords

ESRDThoracic DiseaseKidney Transplant

Outcome Measures

Primary Outcomes (1)

  • Phenotypic Frailty Criteria

    The phenotypic frailty criteria is a validated frailty measurement tool. Phenotypic frailty is a composite that includes grip strength measured via a dynamometer, self-reported weight loss, self-reported exhaustion using a validated two question screen, 15 foot gait speed, and activity level measured by the Minnesota Leisure Time Physical Activity Questionnaire. This will be measured at baseline and 8 weeks.

    8 weeks

Secondary Outcomes (4)

  • Short Physical Performance Battery (SPPB)

    8 weeks

  • Berg Balance Scale

    8 weeks

  • 6 minute walk test

    8 weeks

  • PROMIS Global Health

    8 weeks

Study Arms (1)

High Intensity Walking

EXPERIMENTAL

Participants will then undergo a 12 session intervention, with two sessions scheduled per week for six weeks. These will be 45 minute sessions, including 15 minutes of a warm-up and cool-down period as well as 30 minutes of walking. The intervention will include various types of over ground walking and stair work.

Behavioral: High Intensity Walking

Interventions

Participants will then undergo a 12 session intervention, with two sessions scheduled per week for six weeks. These will be 45 minute sessions, including 15 minutes of a warm-up and cool-down period as well as 30 minutes of walking. The intervention will include various types of over ground walking and stair work.

High Intensity Walking

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Provision of informed consent
  • No obvious contraindication to surgery such as uncontrolled cardiovascular, metabolic, or respiratory disease
  • Have either thoracic disease that may require major surgery or End-Stage Renal Disease or Chronic Kidney Disease under consideration for kidney transplant. The kidney transplant patients enrolled must be either a candidate for living donor transplantation or on the expedited deceased donor kidney transplant list, which indicates they are expected to receive an offer in approximately the next 3-5 months.
  • Able to ambulate at least 10 feet with moderate assistance (\<50% physical assistance)
  • Pre-frail or frail on the FRAIL screening tool (1+ positive on this tool)

You may not qualify if:

  • Surgery planned within the 8 week study timeframe
  • Uncontrolled cardiovascular, metabolic, or respiratory disease that limits exercise participation
  • Resting blood pressure \>180/110
  • Any pre-existing health condition that would make the subject a poor candidate for this study in the opinion of the PI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Chicago

Chicago, Illinois, 60637, United States

Location

MeSH Terms

Conditions

FrailtyKidney Failure, ChronicThoracic Diseases

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsRenal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesRespiratory Tract Diseases

Study Officials

  • Maria L Madariaga, MD

    University of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2020

First Posted

January 27, 2020

Study Start

May 15, 2019

Primary Completion

September 6, 2023

Study Completion

September 6, 2023

Last Updated

October 23, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations